PositiveID testing new detector for BioWatch procurement

Positive ID Corporation is currently conducting tests on a new bioagent detection system that is capable of remotely identifying DNA-based pathogens, with or without either RNA-based organisms or toxins.

Positive ID hopes its M-BAND, or Microfluidics-based Bioagent Autonomous Networked Detector, will be part of the U.S. Department of Homeland Security's $3 billion procurement for the BioWatch program, according to Homeland Security News Wire.

The M-BAND is configured to detect five organisms that are on the U.S. Centers for Disease Control and Prevention Select Agents List, a requirement for BioWatch.

The detector was developed under a DHS contract as an early warning system to monitor for the intentional release of aerosolized biological agents. It can run remotely and autonomously for up to thirty days before being serviced. It can continuously scan and analyze air samples in high-traffic areas and report results in as little as three hours.

"As we prepare for the final request for proposal for BioWatch to be released from DHS, we have continued our internal testing of M-BAND," William J. Caragol, the chairman and CEO of PositiveID, said, Homeland Security News Wire reports. "Our system is fully functional and, we believe, one of the only technologies capable of addressing the requirements of the BioWatch procurement. Furthermore, we believe our system not only performs better than the competition but also has a lower total cost of ownership."